Poly MVA Survivors
Testimonials Written by Cancer Patients
 
.
       
HOME OUR INSPIRATION TESTIMONIALS RESEARCH WHAT YOU MUST KNOW
 

 
What You Must Know
 

The Potential for Vitamin D in Cancer Treatment
Vitamin D deficiency has clearly been shown to be a risk factor in the development of multiple forms of cancer.
This scientific research indicates that maintaining high levels of vitamin D can prevent the progression of cancer & increase survival rates.



SCIENTIFIC RESEARCH ARTICLES
Every Cancer Patient needs to test their Vitamin D levels!

 

Circulating Vitamin D levels in the Blood
Dramatically Reduces Death Rate

* For each 10ng/ml increase in the blood level of vitamin D, the death rate from cancer would be reduced by 29%. The relationship between vitamin D and colorectal cancer is particularly strong. The death rate for colorectal cancer would be reduced by 49%.
(
30 - Read Supporting Scientific Article)

 
----------------------------
Vitamin D Levels
Highest during Summer = Improves survival by 40%

* A Norwegian study showed that cancer patients diagnosed in the summer when vitamin D levels are highest had up to 40% better survival rates than patients diagnosed in the winter when vitamin D levels are at their lowest.
(
56 - Read Supporting Scientific Article )

 
----------------------------
Low Vitamin D Levels
Greater chance of Death & Metastasis

* Breast cancer patients with low levels of vitamin D followed over 11 years had a 70% greater chance of dying and twice the rate of developing metastasis than patients with high levels of vitamin D.
(
90 - Read Supporting Scientific Article )

 
----------------------------
Lung Cancer Patients
Higher levels = Dramatic increase in Survival

* Early stage lung cancer patients who were diagnosed in the summer and had the highest levels of vitamin D had a five-year survival of 73% compared to 30% for those diagnosed in the winter with low vitamin D levels.
(
60 - Read Supporting Scientific Article)

 
----------------------------
Lung - Colon - Prostate - Renal - Endometrial Cancers
Higher Vit D levels dramatically decreases Risk

* High vitamin D levels (based on latitude and UV exposure) also correlate with a decreased risk of developing lung cancer, a 45% and 65% reduction in men and women respectively. Similar effects have been demonstrated in colon, prostate, renal and endometrial cancer.
(
33 - Read Supporting Scientific Article)

 
----------------------------
Advanced Colorectal Patients
Risk of death greatly Improved

* The risk of death for colorectal cancer patients with advanced disease but with high levels of vitamin D was reduced by over 60% compared to patients with low vitamin D levels.
(
64 - Read Supporting Scientific Article)

 
----------------------------
Prostate Cancer Patients
7 Fold reduced risk of Death

* Prostate Cancer Patients with Vitamin D levels in the mid and high range had a 60% and 85% respectively reduced risk of death from the condition compared to patients with low levels of Vitamin D. This is almost a seven fold increase in the risk of death in those with low vs high vitamin D levels.
(
152 - Read Supporting Scientific Article)

 
 
Ask your Doctor for a
25-Hydroxy Vitamin D Blood Test




*Most Cancer Patients have Vitamin D blood levels

below < 40 ng/ml

Don't Be Fooled -- Order the Correct Test

There are two vitamin D tests -- 1,25(OH)D and 25(OH)D.
The correct test is 25(OH)D, also
called

The 25-hydroxy vitamin D blood test

25(OH)D is the better marker of overall D status. It is this marker that is most strongly associated with overall health.

Please note the difference between normal and optimal. You don't want to be average here; you want to be optimally healthy. Primitive man likely developed in tropical and sub-tropical conditions with large exposure to UV-B and its secondary consequence to skin exposure, vitamin D.

Primitive environmental availability of a nutrient does not necessarily establish the higher requirements, but these exposures would have influenced the evolution of the relevant physiology, and such concentrations should at least be considered presumptively acceptable.

Some experts may disagree with the following healthy ranges, but they are taken from healthy people in tropical or subtropical parts of the world, where they are receiving healthy sun exposures. It seems more than reasonable to assume that these values are in fact reflective of an optimal human requirement.

 
 
 


Cancer's Favorite Food - Found in Everything You Eat?
Posted By Dr. Mercola | August 27 2010

Check the ingredients of everything you eat or drink!



Nationally Recognized Doctor talks about High Fructose Corn Syrup


Click below to read important article
"Cancer Patients must avoid Sugars like Fructose"



MSNBC Article
Cancer Cells feed on fructose, study finds


Click here to Read Article

Reuters Article
Cancer Cells Slurp up fructose, US study finds


Click here to Read Article

 
 
 
 

 
In 2007, KGK Synergize Inc., an independent laboratory in Canada, examined the effects of POLY-MVA on 8 cancer cell lines.

These lines included:
1) Skin melanoma, human (SKMel-5)
2) Liver, hepatocellular carcinoma, human (Hep G2)
3) Lung, malignant melanoma, human (Malme-3M)
4) Mammary gland, ductal carcinoma, human (MDA-MB 435)
5) Prostate, left supraclavicular lymph node carcinoma, human (LNCaP)
6) Colon, colorectal adenocarcinoma, human (HT-29)
7) Human brain, glioblastoma; astrocytoma (U87)
8) Glioblastoma (HT-80)
 
POLY-MVA was administered at 3 different dosages and the number of cells was examined after 24, 48 and 72 hours following initial application. POLY-MVA was effective, to varying degrees, on the entire group of cell lines tested
(melanoma, liver, lung, breast, prostate, colon, astrocytoma and glioblastoma).
.
The varying effectiveness appears to be a consequence of the particular cell lines used and their associated degree of anaplasia.
 
The graph below demonstrates the benefit of POLY-MVA after 48 hours of initial exposure:
The Y-axis represents the number of cells per mL.
 
 
 
 
Poly MVA causes significant cell death after 48 Hours of exposure 
per mL.  SHAPE  \* MERGEFORMAT CPM
The table below illustrates the statistically significant level of cell death
(p must be equal to or less than 0.05) induced by POLY-MVA after 48 hours of initial exposure: 

 

Cancer Cell Type

 

 

Cell Line

Statistical Significance

 

Dosages (ug/ml)

Melanoma

SKMel-5

p<0.01

100, 1000

Liver

Hep G2

p<0.01

1000

Lung

Malme-3M

p<0.0004

100, 1000

Breast

MDA-MB 435

p<0.001

1000

Prostate

LNCaP

p<0.0005

1000

Colon

HT-29

p<0.03

10, 100, 1000

Astrocytoma

U-87

p<0.05; p<0.01

10, 100; 1000

Glioblastoma

HT-80

p<0.0001

10, 100, 1000

 
 
 
Garnett McKeen In vitro Cancer Assays:
Garnett McKeen Laboratory Inc. (GML) chose to mimic the National Cancer Institute’s (NCI) cell screening protocol.
 

The following cell lines were selected from the NCI repository:

MCF-7 (breast adenocarcinoma), and A549 (lung non-small cell adenocarcinoma).

 

The data below represents the completion of the Breast Cancer (MCF-7), Ovarian Cancer (OVCAR-5) and Lung Carcinoma (A549) assay.

 

We have also completed assays using stage IV glioblastoma multiforme (H-80) and astrocytoma (H-4) brain tumor lines.

 

As noted below, all of the studies demonstrated significant cell death.

 

.
CANCER CELL DEATH RATE IN 5 CELL LINES 
After 48 hours of exposure
 
 

Breast Cancer

(Adenocarcinoma)

91.1%

Breast Cancer Cell Death after 48 Hours

Ovarian Cancer

(Adenocarcinoma)

92.07%

Ovarian Cancer Cell Death after 48 Hours

 
 
 

Lung Cancer

(Non-Small Cell Carcinoma)

83.8% Percentage

Lung Cancer Cell Death after 48 Hours

 

 
 
Brain Tumor
(Glioblastoma)
96.3% Percentage
Brain Cancer Cell Death after 48 Hours
Brain Tumor
(Astrocytoma)
82.5% Percentage
Brain Cancer Cell Death after 48 Hours
   
 

 


 

.
For Doctors and Patients
.


Oncologist touts the benefits of Poly-MVA(LAPd)

.

James Forsythe, MD, HMD

Century Wellness Clinic in Reno, NV

.

"The long-term positive impact I have seen in our clinic is quite astounding. Since 2004, we've performed 3 outcome studies in over 1700 patients with Poly-MVA(LAPd).

.

Poly-MVA provides a significant difference as a stand-alone or Integrative Protocol and also continues to show outstanding impact for each patient's success & overall health."

Stage IV Study -  1,000 Patients
.


 
.
 
©2017 All Rights Reserved
 
The Poly MVA Survivors website is designed for educational purposes only, and is not engaged in rendering specific medical advice or professional services. The information provided through this website should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care.